Overview
Vishal Patel is a Hepatologist in Fountain Hill, Pennsylvania. Dr. Patel is rated as an Advanced provider by MediFind in the treatment of Fibrolamellar Carcinoma. His top areas of expertise are Hepatitis C, Hepatitis, Alcoholic Cirrhosis, and Visceromegaly.
His clinical research consists of co-authoring 6 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- INSURANCE PLAN
- OTHER COMMERCIAL
- MEDICARE PDP
- EPO
- HMO
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- OTHER MEDICARE PART D
- HMO
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- EPO
- HMO
- PPO
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- PPO
- HMO
- MANAGED MEDICAID PLAN
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
701 Ostrum St, Suite 201, Fountain Hill, PA 18015
100 E Lancaster Ave, Wynewood, PA 19096
Additional Areas of Focus
Dr. Patel has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Einstein Practice Plan Inc
Richard Kalman is a Hepatologist in Phila, Pennsylvania. Dr. Kalman is rated as a Distinguished provider by MediFind in the treatment of Fibrolamellar Carcinoma. His top areas of expertise are Hepatitis, Visceromegaly, Liver Failure, Endoscopy, and Liver Transplant.
Jefferson University Physicians
Jonathan Fenkel is a Hepatologist in Philadelphia, Pennsylvania. Dr. Fenkel is rated as a Distinguished provider by MediFind in the treatment of Fibrolamellar Carcinoma. His top areas of expertise are Hepatitis, Hepatitis C, Ascites, Liver Transplant, and Endoscopy.
Jefferson University Physicians
David Sass is a Hepatologist in Philadelphia, Pennsylvania. Dr. Sass is rated as a Distinguished provider by MediFind in the treatment of Fibrolamellar Carcinoma. His top areas of expertise are Enlarged Liver, Ascites, Hepatitis, Liver Transplant, and Endoscopy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Alcoholic CirrhosisDr. Patel isAdvanced. Learn about Alcoholic Cirrhosis.
- AscitesDr. Patel isAdvanced. Learn about Ascites.
- CirrhosisDr. Patel isAdvanced. Learn about Cirrhosis.
- Enlarged LiverDr. Patel isAdvanced. Learn about Enlarged Liver.
- Esophageal VaricesDr. Patel isAdvanced. Learn about Esophageal Varices.
- Fibrolamellar CarcinomaDr. Patel isAdvanced. Learn about Fibrolamellar Carcinoma.
- Experienced
- Autoimmune HepatitisDr. Patel isExperienced. Learn about Autoimmune Hepatitis.
- Banti's SyndromeDr. Patel isExperienced. Learn about Banti's Syndrome.
- JaundiceDr. Patel isExperienced. Learn about Jaundice.
- MacroamylasemiaDr. Patel isExperienced. Learn about Macroamylasemia.
- Non-Alcoholic Fatty Liver DiseaseDr. Patel isExperienced. Learn about Non-Alcoholic Fatty Liver Disease.
- Nonalcoholic Steatohepatitis (NASH)Dr. Patel isExperienced. Learn about Nonalcoholic Steatohepatitis (NASH).